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Phagosomal signaling by Borrelia burgdorferi in human
monocytes involves Toll-like receptor (TLR) 2 and TLR8
cooperativity and TLR8-mediated induction of IFN-β
Jorge L. Cervantesa, Star M. Dunham-Emsb, Carson J. La Vakea, Mary M. Petzkec, Bikash Sahayd, Timothy J. Sellatid,
Justin D. Radolfa,b,e, and Juan C. Salazara,f,1
Departments of aPediatrics, bMedicine, and eGenetics and Developmental Biology, University of Connecticut Health Center, Farmington, CT 06030;
c
Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595; dCenter for Immunology and Microbial Disease, Albany
Medical College, Albany, NY 12208; and fDivision of Pediatric Infectious Diseases, Connecticut Children’s Medical Center, Hartford, CT 06106

Phagocytosed Borrelia burgdorferi (Bb) induces inﬂammatory signals that differ both quantitatively and qualitatively from those
generated by spirochetal lipoproteins interacting with Toll-like receptor (TLR) 1/2 on the surface of human monocytes. Of particular
signiﬁcance, and in contrast to lipoproteins, internalized spirochetes induce transcription of IFN-β. Using inhibitory immunoregulatory DNA sequences (IRSs) speciﬁc to TLR7, TLR8, and TLR9, we
show that the TLR8 inhibitor IRS957 signiﬁcantly diminishes production of TNF-α, IL-6, and IL-10 and completely abrogates transcription of IFN-β in Bb-stimulated monocytes. We demonstrate
that live Bb induces transcription of TLR2 and TLR8, whereas
IRS957 interferes with their transcriptional regulation. Using confocal and epiﬂuorescence microscopy, we show that baseline TLR
expression in unstimulated monocytes is greater for TLR2 than for
TLR8, whereas expression of both TLRs increases signiﬁcantly
upon stimulation with live spirochetes. By confocal microscopy,
we show that TLR2 colocalization with Bb coincides with binding,
uptake, and formation of the phagosomal vacuole, whereas recruitment of both TLR2 and TLR8 overlaps with degradation of the spirochete. We provide evidence that IFN regulatory factor (IRF) 7 is
translocated into the nucleus of Bb-infected monocytes, suggesting
its activation through phosphorylation. Taken together, these ﬁndings indicate that the phagosome is an efﬁcient platform for the
recognition of diverse ligands; in the case of Bb, phagosomal signaling involves a cooperative interaction between TLR2 and TLR8
in pro- and antiinﬂammatory cytokine responses, whereas TLR8 is
solely responsible for IRF7-mediated induction of IFN-β.
Lyme disease
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L

yme disease (LD), the most commonly reported vector-borne
illness in the United States (1), is a multisystem infectious
disorder caused by the spirochetal bacterium Borrelia burgdorferi
(Bb). Monocytes and macrophages are considered to be critical
cellular elements of the innate immune response to Bb (2–5).
Recognition of the spirochete was previously thought to result
primarily from the interactions of the bacterium’s abundant outer
membrane-associated lipoproteins with Toll-like receptor (TLR)
1/2 on the surface of innate immune cells (6). More recently, we
and others have provided evidence that phagocytosed live Bb
induces inﬂammatory signals that differ both quantitatively and
qualitatively from those generated by lipoproteins (2, 4, 7–9). In
addition to enhanced cytokine production, phagocytosed live Bb
induced transcription of IFN-β and several IFN-stimulated genes
(ISGs) in isolated human monocytes, whereas spirochetal lipoproteins were unable to do so (7).
Although production of type I IFNs was previously ascribed
solely to antiviral immune responses (10), it now is well established that both intracellular (11–14) and extracellular bacteria
(11, 15–17) also induce transcription of these cytokines. Bacteria
can elicit type I IFNs either by activating TLRs (11, 12) or
through TLR-independent recognition of bacterial pathogen-
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associated molecular patterns (PAMPs) within the host cell cytosol (11, 18). We and others have begun to demarcate the
pathways by which live Bb induces type I IFNs in both mouse and
human cells (7, 19–22). Miller et al. (20) demonstrated that live
Bb induces transcription of several ISGs in bone marrow-derived
murine macrophages (BMDMs) independent of both MyD88
(20) and TRIF (21) yet requiring the transcription factor IFN
regulatory factor (IRF) 3. Using Bb-infected human peripheral
blood mononuclear cells (PBMCs), Petzke et al. (22) provided
evidence that human plasmacytoid dendritic cells (pDCs) are a
principal source of IFN-α in response to phagocytosed live spirochetes and demonstrated that transcription and secretion of
this type I IFN was inhibited by blocking TLR7 and TLR9. These
two TLRs, together with TLR8, make up a family of endosomal
pattern recognition receptors that are capable of generating
MyD88-dependent type I IFNs by sensing pathogen-derived
nucleic acids (23, 24). In contrast to pDCs, human monocytes
constitutively express TLR8, and although they also express
TLR7, they do not express TLR9 (23, 25–27). The role of TLR8 in
modulating innate immune responses to Bb, including its involvement in the production of type I IFNs, has not been
previously examined.
In this study, we used highly puriﬁed human monocytes to
characterize more precisely the mechanisms whereby internalization of the LD spirochete induces production of pro- and
antiinﬂammatory cytokines, including type I IFNs. We provide
evidence that phagosomal signaling in Bb-infected monocytes
involves a sequential and cooperative interaction between TLR2
and TLR8, which occurs exclusively by activation of TLR8 in the
case of IFN-β. Our combined observations take us well beyond the
simplistic notion that innate immune cell activation by Bb occurs
only at the plasma membrane through TLR1/2 and CD14 signaling and, instead, reveal the importance of the phagosome as an
efﬁcient platform for the recognition of diverse bacterial PAMPs.
Results
Phagocytosis of Bb Is Required for Transcription of IFN-β in BbInfected Human Monocytes. We previously showed that in-

hibition of phagocytosis diminished NF-κB–dependent cytokine
production in Bb-stimulated PBMCs (2). More recently, we
demonstrated that the monocyte is a major source of these
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cytokines and solely responsible for the production of IFN-β (7).
We now provide evidence that internalization of the bacterium is
essential for the induction of IFN-β and for optimal production
of TNF-α in isolated human monocytes. When the actin ﬁlament
disrupter Cytochalasin-D is used to block phagocytosis, transcription of ifnb is abrogated and secretion of TNF-α is signiﬁcantly diminished (Fig. S1). Thus, if sensing of the spirochete is
restricted to cell surface TLR2, induction of type I IFNs does not
occur and production of NF-κB–mediated cytokines is signiﬁcantly impaired.
Bb-Mediated Induction of IFN-β Cannot Be Explained by TLR2
Signaling. TLR2 signals were previously believed to be incapa-

ble of inducing type I IFNs (28). Two recent studies have challenged this notion by demonstrating that activation of TLR2, by
either viral (29) or bacterial (30) ligands, can induce transcription
of IFN-β in inﬂammatory human monocytes and murine macrophages, respectively. In a previous study, we provided evidence
that lipoprotein-rich borrelial lysates do not induce transcription
of IFN-β by human monocytes (7). In the same study, we showed
that production of IFN-β in Bb-infected murine BMDMs occurs
independent of TLR2. Nonetheless, in light of the recent ﬁnding
that a bacterial TLR2 ligand (Pam3CSK4) induces production of
IFN-β in murine macrophages (30), we have reexamined herein
the contribution of TLR2 activation in the production of this cytokine by human monocytes. We ﬁrst established that transcription of IFN-β in Bb-stimulated monocytes does not begin in
earnest until 2 h of incubation and increases noticeably after 4 h
of stimulation (Fig. S2). In contrast to the robust type I IFN responses elicited by either LPS or live Bb, even high concentrations
of Pam3CSSNA failed to induce transcription of IFN-β in monocytes (Fig. S3). These combined observations are indicative that
TLR2 signaling does not play a signiﬁcant role in the induction of
type I IFNs in Bb-infected monocytes.
TLR8 Is Required for Transcription of IFN-β and Cooperates with TLR2
in Generating Pro- and Antiinﬂammatory Cytokine Production in Human Monocytes. Having established that TLR2 signaling alone

cannot explain the type I IFN responses to live Bb, we hypothesized that activation of an endosomal TLR could be responsible
for the induction of IFN-β in the monocyte. To explore this
possibility, we took advantage of the availability of speciﬁc inhibitory DNA–oligonucleotide sequences (IRSs) that have the
ability to block ligation of TLR7, TLR8, or TLR9 (31, 32). These
inhibitors were recently used by Petzke et al. (22) to demonstrate
that induction of IFN-α in Bb-infected pDCs is dependent on
TLR7 and TLR9. For these experiments, we ﬁrst corroborated
that healthy volunteers’ monocytes expressed TLR7 and TLR8
and very little TLR9 (27) (Table S1). As depicted in Fig. 1A, we
then showed that inhibition of TLR8 by IRS957 eliminated
transcription of IFN-β, whereas induction of this cytokine by the
spirochete was unaffected by blocking TLR7 with IRS661
(P = 0.17 vs. no inhibitor) or TLR9 with IRS869 (P = 0.27 vs. no
inhibitor). The speciﬁcity of IRS957 for TLR8 in human monocytes has been previously conﬁrmed by exclusion of reactivity to
TLR7 and TLR9 (32). Herein, we conﬁrmed the speciﬁc inhibitory effect of IRS957 by demonstrating that production of
IFN-β was markedly decreased in response to the TLR7/8 agonist R848 (Fig. S4) and the TLR8-speciﬁc ligand 3M-002 (Fig.
S5), whereas TLR7 inhibition had no effect on 3M-002–mediated
transcription of IFN-β. Moreover, the response to LPS, which
induces IFN-β through TLR4 (28), was unaffected by the TLR8
inhibitor (Fig. 1A). In concert with the role of TLR8 in the production of NF-κB–dependent cytokines (33–35), IRS957 also
caused a signiﬁcant decrease in secretion of TNF-α, IL-6, and IL10 by Bb-infected monocytes (Fig. 1B). In parallel experiments, we
veriﬁed using confocal microscopy that internalization of the spirochete was not signiﬁcantly affected by blocking TLR8 (no in3684 | www.pnas.org/cgi/doi/10.1073/pnas.1013776108

Fig. 1. Transcription of IFN-β is abrogated after TLR8 inhibition in human
monocytes. (A) TLR8 inhibition by IRS-957 eliminated transcription of IFN-β in
Bb-infected monocytes (10:1 multiplicity of infection), whereas a control
ODN sequence did not. Transcription of IFN-β in response to LPS was not
affected by either treatment. Relative expression refers to ifnb gene expression normalized to gapdh. N.S., not signiﬁcant; ODN, oligodeoxyribonucleotide. (B) Secretion of NF-κB–dependent cytokines (TNF-α, IL-6, IL10, and IL-1β) was diminished on inhibition of TLR8 in human monocytes. Un,
uninfected. P values correspond to paired analysis [Mann–Whitney U test (A)
and paired t test (B)] from a minimum of four independent experiments.
*P < 0.05; **P < 0.01.

hibition, 19.2% ± 4.1 vs. TLR8 inhibited, 14.2% ± 1.2; P = 0.2).
Taken as a whole, we interpreted these results as evidence that in
Bb-infected monocytes, TLR8 cooperates with TLR2 in the production of NF-ĸB–mediated cytokines, whereas TLR8 alone is
responsible for transcription of IFN-β.
We next used RT-PCR to examine the expression proﬁle of
TLR2 and TLR8 in Bb-infected monocytes and compared these
responses with those elicited by synthetic TLR2 and TLR8 ligands.
As shown in Table 1, live Bb differentially induced transcription
of both TLR2 and TLR8, although it had no effect on TLR7
or TLR9. In parallel experiments, we demonstrated that upregulation of both TLR2 and TLR8 was greatly diminished by
blocking TLR8 (Table 1). The inhibitory effect of IRS957 on
TLR8 protein levels was conﬁrmed by Western blot analysis (Fig.
S6). The regulatory effect of TLR8 stimulation on TLR2 is not at
all unanticipated, given that IFN-β has been shown to up-regulate
expression of TLR2 (36). In support of this idea, R848 induced
transcription of both TLR8 and TLR2 (Table 1), whereas
Pam3CSSNA only affected TLR2. The inhibitory effect of IRS957
on TLR8 transcription is indicative that TLR8 is self-regulated on
engagement of its cognate spirochetal PAMP. These ﬁndings
Cervantes et al.

Table 1. TLR relative expression in stimulated human
monocytes
Bb, 10:1 MOI
n=6
TLR2
TLR8
TLR7
TLR9

No inhibitor
3.1
5.8
1.4
−3.6

±
±
±
±

0.5
0.7
0.1
0.9

TLR8-inhibited
1.9
−1.5
−0.4
−2.5

±
±
±
±

0.2*
0.6*
1.2*
0.7

Pam3CSSNA,10 μg
2.8
−0.4
−1.3
−1.5

±
±
±
±

1.7
1.9
0.2
0.5

R848,1 μg
2.2
14.2
3.6
−3.1

±
±
±
±

0.4
4.3
2.7
1.3

Values represent relative changes in gene expression compared with
GAPDH. MOI, multiplicity of infection.
*P < 0.05 (Mann–Whitney U test). Comparison analysis between TLR8inhibited and -uninhibited Bb-stimulated monocytes.

TLR2 and TLR8 Colocalize with GFP-Bb to the Phagosomal Vacuole of
the Monocyte. Having established that phagocytosis is an essential

element of the innate immune response to the spirochete and
that TLR2 and TLR8 cooperate in generating phagosomal signals, we then used confocal microscopy to characterize the
spatial-temporal distributions between phagocytosed Bb and
TLR2 and TLR8 more precisely. We ﬁrst showed that the
baseline expression of TLR2 in unstimulated monocytes was
greater than that of TLR8 (Fig. 2 and Fig. S7). TLR2 was visualized on the monocyte’s surface as well as on the cytoplasm,
whereas TLR8 was seen exclusively inside the cell. Within 30 min
of coincubation with Bb, expression of both TLR2 and TLR8
increased in Bb-infected monocytes and to a lesser extent in
bystander uninfected cells (Fig. 2 and Fig. S7). To capture spirochete-TLR localization at both early and later stages of
phagocytosis, we analyzed multiple confocal images obtained at
several times of incubation, beginning with the 30-min stimulation time point. TLR2 colocalized at the cell surface with spirochetes that were attached and/or partially embedded in the
monocyte’s membrane (Fig. 3A and Movie S1). TLR2 also
colocalized to the phagosomal vacuole, with recently internalized
spirochetes shown as tightly wound bacterial coils (Fig. 3B and
Movie S2). TLR8 colocalized to phagosomal vacuoles containing
fully degraded spirochetes in the shape of bright ﬂuorescent
blebs (Fig. 3C and Movie S3). Concurrent staining with TLR2
and TLR8 conﬁrmed that both TLRs colocalize simultaneously
to phagosomal vacuoles containing degraded spirochetes (Movie
S4). Of particular signiﬁcance, TLR2 colocalized with TLR8 in
the cytoplasm of Bb-infected monocytes (Fig. 2, Inset and Movie
S4), which suggests that TLR2 and TLR8 trafﬁc to the phagosome from similar endosomal compartments. Taken together,
these images provide visual evidence that Bb is initially sensed by
TLR2 on the monocyte cell surface during binding and uptake,
whereas partially and fully degraded spirochetes interact with
both TLR2 and TLR8 in the phagosomal vacuole.
Live Bb Induces Transcription and Nuclear Translocation of IRF7. We
next sought to elucidate which transcription factor is associated
with TLR8-mediated induction of IFN-β. We focused on IRF3,
IRF5, and IRF7, all of which are associated with the induction of
genes that encode type I IFNs (37–41). We have previously
demonstrated that IRF7 is the only IRF that is signiﬁcantly upregulated in PBMCs stimulated with live Bb (7). Herein, we show
by RT-PCR that IRF7 (but not IRF3 or IRF5) is also induced in
Bb-infected isolated human monocytes (Table 2). We also demonstrate that the transcriptional regulation of IRF7 is eliminated
by blocking TLR8. Using epiﬂuorescence microscopy, we then
conﬁrmed that IRF7 is translocated into the nucleus of BbCervantes et al.

Fig. 2. TLR2 and TLR8 cellular expression. Costaining for TLR2 (green) and
TLR8 (red) is shown in unstimulated monocytes and in both infected and
uninfected cells (bystander) within 30 min of incubation with Bb (10:1 multiplicity of infection). TLR2 ﬂuorescent signals are visualized in unstimulated
and bystander cells, greatly increasing in Bb-infected monocytes. TLR8 signals
are of very low intensity in uninfected monocytes and, like TLR2, increase in
Bb-infected monocytes. Black arrows point to degraded GFP-Bb. TLR2 colocalizes with TLR8 even at locations that do not coincide with internalized GFPBb (white arrows and region of interest). Numerical values shown in white
correspond to Mander’s colocalization coefﬁcient (M2), indicative of the
proportion of the green signal (TLR2) overlapping with the signal in the red
channel (TLR8). DIC, differential interference contrast.

infected monocytes and R848-stimulated cells (Fig. 4), a ﬁnding
that is indicative of IRF7 activation through phosphorylation (42).
A similar process did not occur in unstimulated monocytes or
bystander uninfected cells. A two-step process involving IRF3
activation before activation of IRF7 does not seem plausible,
because we did not observe any increase in IRF3 signal by mi-
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provide additional evidence that innate immune responses to Bb in
human monocytes result from a cooperative interaction between
TLR2 and TLR8.

Fig. 3. Phagocytosed Bb colocalizes with TLR2 and TLR8 in human monocytes. A composite of representative confocal micrographs shows three
consecutive Z-stack planes of GFP-Bb–stimulated human monocytes. Extracellular Bb interacts with TLR2 at the plasma membrane of the monocyte (A),
whereas recently internalized (bacterial coil) and fully degraded (ﬂuorescent
bleb) Bb colocalizes with TLR2 (B) and TLR8 (C). Mander’s colocalization
coefﬁcient values (M2), shown in the upper right corner of each ﬁgure, are
indicative of the proportion of the green signal overlapping with the signal
in the red channel. Red depicts TLR2 signals in A and B and TLR8 in C, green
depicts GFP-Bb, and white represents red and green pixels that colocalize.
(Scale bar, 5 μm.) Colocalization through the Z-stack images illustrated in A
and B (TLR2) and in C (TLR8) is shown in Movie S1, Movie S2, and Movie S3.

PNAS | March 1, 2011 | vol. 108 | no. 9 | 3685

Table 2. IRF Expression in Bb-stimulated human monocytes
n=6

No inhibitor

TLR8-inhibited

IRF 3
IRF 5
IRF 7

−1.1 ± 0.5*
0.03 ± 0.6*
7.2 ± 1.3*

−2.1 ± 0.1
−2.2 ± 0.3
1.6 ± 0.1

Values represent relative changes in gene expression compared with
GAPDH.
*P < 0.05 (Mann–Whitney U test). Comparison analysis between inhibited
and uninhibited Bb-stimulated human monocytes.

croscopy or translocation of IRF3 into the nucleus (Fig. S8).
Moreover, using Bb-infected monocytes in a time-chase experiment, we conﬁrmed that relative increases in IRF7 sequentially
preceded relative increases in IFN-β (Fig. S2). Blocking IRF7
phosphorylation using the kinase inhibitor staurosporine (43)
completely abrogated IFN-β induction (Fig. S9A) and greatly
impaired up-regulation of IRF7 (Fig. S9B). The amount of
staurosporine used was enough to block nuclear translocation of
IRF7 in the absence of apoptosis (Fig. S9C). Taken as a whole,
these results provide evidence that IRF7 induces transcription of
IFN-β in Bb-infected monocytes.
Discussion
The experimental evidence presented herein indicates that the LD
spirochete induces multifaceted innate inﬂammatory signals in
human monocytes that can only be fully coordinated during internalization of the bacterium and formation of the phagosome. As
maturation of the phagosome progresses, this unique vacuolar
structure very quickly gains capabilities for the recognition of diverse spirochetal PAMPs and becomes an increasingly more efﬁcient platform for signal generation, leading to enhanced production of NF-ĸB–mediated cytokines and MyD88-dependent
induction of IFN-β. Our ﬁndings are unique in that they suggest that
internalization and degradation of the spirochete by the monocyte

Fig. 4. Live Bb induces nuclear translocation of IRF7. IRF7 (red) is expressed
in the cytoplasm of uninfected monocytes and translocates to the nucleus
(DAPI, blue) in GFP-Bb–infected monocytes (indicated by black arrows) and
in R848-stimulated controls. Translocation of IRF7 into the nucleus is shown
in pink. BF, bright ﬁeld.

3686 | www.pnas.org/cgi/doi/10.1073/pnas.1013776108

facilitates sampling of liberated PAMPs through a sequential activation of cell surface TLR2, followed by signaling through TLR2
and TLR8 cooperatively at the phagosomal membrane.
Mammalian TLR8 is thought to signal exclusively through
MyD88 after recognition of single-stranded RNA ligands (44).
Human TLR8 can be activated by nucleic acids derived from
a variety of RNA viruses (45–48) as well as Escherichia coli RNA
in genetically complemented HEK293 cells (49). To date, TLR8
has been linked to the recognition of two different intracellular
bacteria, Mycobacterium bovis bacille Calmette–Guérin (bacillus
Calmette–Guérin) (35) and Helicobacter pylori (50). In the case of
bacillus Calmette–Guérin, TLR8 protein expression levels markedly increased in infected macrophages derived from a human
acute monocytic leukemia cell line (THP-1 cells). Interestingly,
a signiﬁcant boost in TLR8 expression levels was also seen in the
blood of patients with untreated Mycobacterium tuberculosis infection (50). Using activated THP-1 cells, Gantier et al. (35)
demonstrated that expression of the two main human TLR8
variant mRNAs signiﬁcantly increased following H. pylori
phagocytosis. In this study, we reveal a previously unappreciated
direct role for human TLR8 in transcription of IFN-β in Bbinfected monocytes and cooperativity with TLR2 in the production of several NF-κB–dependent cytokines. We hypothesize
that endosomal TLR8 is activated in response to spirochetal
mRNA released upon degradation of the bacterium into the
phagosomal cargo. In contrast to bacillus Calmette–Guérin and
H. pylori, Bb is an extracellular pathogen that is rapidly degraded
once phagocytosed; thus, it is not surprising that engagement of
TLR8 in the monocytes occurred soon after internalization of the
bacterium. Given that induction of type I IFNs in Bb-infected
pDCs is partially dependent on TLR9 (22), it is conceivable that
borrelial DNA also may play a role in activating TLR8 in human
monocytes. This premise is supported by the recent ﬁnding that
murine TLR8, which is functional in mice in the context of a viral
infection (51), can be activated by vaccinia virus (VV) DNA
through recognition of poly(A)T-rich motifs (52). Like VV DNA,
borrelial DNA also contains poly(A)T-rich motifs (53).
TLR2–spirochetal PAMP interactions were originally studied
as cell surface phenomena (54). Several studies have now demonstrated that TLR2 is recruited to the phagosome, where it
becomes available for signaling (14, 55–57). Structurally, this
model is not at all unanticipated, given that the phagosomal
membrane is initially derived from the plasma membrane (58,
59). Consistent with this concept, Underhill et al. (55) found that
in a mouse leukemic monocyte macrophage cell line (RAWcells), cell surface TLR2 was recruited to phagosomes and colocalized with zymosan particles within minutes of their internalization, suggesting that TLR2-mediated signals occur within
a circumscribed window of time during the initial phase of
phagosome maturation. Studies conducted in Stephanie Vogel’s
laboratory (60), however, have revealed that prolonged TLR2dependent signaling from the phagosomal vacuole takes place in
murine macrophages infected with a mutant strain of Francisella
tularensis (Ft), which is unable to escape the phagosome. The
same group demonstrated that TLR2 and MyD88 colocalize to
the phagosomal vacuole of RAW macrophages infected with
a live vaccine Ft strain (14). TLR2 also can become available for
signaling from within endosomal vacuoles in human monocytes
stimulated with internalized staphylococcal lipoteichoic acid (56).
O’Connell et al. (57) demonstrated that intracellular TLR2 was
responsible for the initiation of signal transduction events by
Chlamydia trachomatis. Herein, we validate that TLR2 senses live
spirochetes at the plasma membrane during binding and uptake
and provide previously undescribed evidence that TLR2 is also
available for signaling at the phagosomal membrane of human
monocytes. The ﬁnding that TLR2 colocalizes with TLR8 intracellularly in areas other than the phagosome (Fig. 4, region of
interest) suggests that TLR2 trafﬁcs to the phagosomal vacuole
Cervantes et al.

Materials and Methods
Human Monocyte Isolation and Stimulation Conditions. All procedures involving human subjects were approved by the Institutional Review Board at
the University of Connecticut Health Center. After obtaining written informed
consent, monocytes were isolated from LD-seronegative volunteers as previously described (7). Except where noted, cells were incubated for 4 h at 37 °C/
5% (vol/vol) CO2 with live, low-passage, temperature-shifted GFP-Bb 1479 at
various multiplicities of infection. Appropriate controls, including a synthetic
TLR2 ligand (Pam3CSSNA), were used in the ex vivo stimulation model as
previously described (7). All culture media and reagents were conﬁrmed to be
essentially free of LPS contamination (<10 pg/mL) by Limulus amoebocyte
lysate assay (Cambrex). In selected experiments, Cytochalasin-D was used as
previously described (2).
Endosomal TLR Blocking. Speciﬁc immunoregulatory DNA sequences (IRSs;
Integrated DNA Technologies) (31) were used to block TLR7 signaling (IRS661:
5′-TGCTTGCAAGCTTGCAAGCA-3′), TLR7 and TLR8 (IRS957: 5′-TGCTTG-ACATCCTGGAGGGGTTGT-3′), and TLR9 (IRS869: 5′-TCCTGGAGGGGTTGT-3′) as
described by Petzke et al. (22). A non–TLR-speciﬁc oligodeoxyribonucleotide
sequence was used as a control, in the same concentration as the TLR inhibitor. R848 (Resiquimod; InvivoGen), a known synthetic ligand for human
TLR7 and TLR8 (32) and a potent inducer of IFN-β (65), was used to study the
response in monocytes. The speciﬁcity of the TLR7 and TLR8 inhibitors was
assessed with the TLR8-speciﬁc ligand 3M-002 (InvivoGen) (66).
Assessment of Monocyte Activation by Quantitative RT-PCR and Cytokine
Secretion. At the conclusion of the incubation period, cells were harvested and
RNA was extracted using a total RNA isolation kit (Macherey–Nagel). cDNA
was prepared from extracted RNA using a high-capacity cDNA RT kit (Applied
Biosystems). RT-PCR conditions and reactions have been described previously (7). Commercially available primers (Applied Biosystems) used for ampliﬁcation included the following: ifnb (Hs00277188_s1), tlr2 (Hs00610101_m1),
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tlr7 (Hs00152971_m1), tlr8 (Hs00152972_m1), tlr9 (Hs00152973_m1), irf3
(Hs01547283_m1), irf5 (Hs00158114_m1), irf7 (Hs00185375_m1), and gapdh
(Hs99999905_m1). Expression levels of all transcripts studied were normalized
to the GAPDH level, and the relative changes in gene expression generated
were calculated using the 2−ΔΔCT method. A cytokine bead array system
(Human inﬂammation kit; Becton Dickinson) was used to assay cytokines secreted by TNF-α, IL-10, IL-6, and IL-1β in culture supernatants. Secretion of IFNβ was determined using a commercially available ELISA method (VeriKine-HS;
PBL Biomedical Laboratories).
Western Blot Analysis of TLR8 Protein Expression. TLR8 expression was measured by Western blot analysis. Brieﬂy, 40 μg of protein was loaded in each
correspondent lane, and protein was transferred to a PVDF membrane. After blocking, the membrane was probed with TLR8 antibody (catalog no.
H00051311-MO1; Abnova). Membranes were washed, and secondary antibodies were added. After 1 h, membranes were washed with PBS-Tween and
developed. The same membrane was stripped, reblocked, reprobed, and
developed for human GAPDH (Santa Cruz Biotechnology, Inc.) Densitometric
analysis of obtained bands was done using a Flurchem 8900 Chemiluminescence and Gel Imager (Alpha Innotech).
Cellular Localization of IRF7/IRF3, TLR8/TLR2, and GFP-Bb. To determine the
cellular localization of TLR2 and TLR8 in Bb-infected monocytes, we used
a modiﬁed version of the method described by Ma et al. (67). Brieﬂy,
monocytes were plated in poly-D-lysine–treated culture slides (BioCoat; BD
Biosciences). Following different time points of stimulation (0 min, 30 min,
60 min, 90 min, 3 h, and 4 h), slides were ﬁxed with 4% (vol/vol) paraformaldehyde for 10 min at room temperature (RT); permeabilized with
0.2% saponin for 10 min; blocked with Connaught Medical Research Laboratories (CMRL) 10% FCS for 2 h at RT; incubated overnight at 4 °C with
a rabbit anti-human IRF7 polyclonal or mouse anti-human IRF3 monoclonal
antibody (Santa Cruz Biotechnology, Inc.), a rabbit anti-TLR8 polyclonal
antibody (IMGENEX), or a rabbit anti-TLR2 polyclonal antibody (Rockland
Immunochemicals) (1:100 dilution for all); and subsequently incubated with
Texas RedR-X–conjugated goat anti-rabbit antibody (1:200 dilution; Invitrogen) for 1 h at RT or goat anti-mouse DyLight 594 (Thermo Scientiﬁc). For
TLR2 and TLR8 immunoﬂuorescent costaining, we used the following antibodies: a primary monoclonal mouse antibody to human TLR8 (IMGENEX)
followed by goat anti-mouse AlexaFluor 546 (Invitrogen) and a primary
polyclonal rabbit anti-TLR2 antibody (Rockland Immunochemicals) followed
by goat anti-rabbit AlexaFluor 635 (Invitrogen). Slides were washed and
mounted in Vectashield antifade reagent (Invitrogen) containing DAPI.
Images were acquired on an LSM-510 confocal microscope using a 63× (1.4
N.A.) oil immersion objective at a pixel resolution of 512 × 512. Image
analysis was performed using ImageJ (National Institutes of Health); pixel
colocalization was displayed using the colocalization plug-in. Mander’s
overlap colocalization coefﬁcients (M1 and M2) were determined using the
JACoP plug-in (68). Movies were generated using ImageJ and Quicktime Pro
software (Apple, Inc.). To measure TLR2 and TLR8 cellular expression, ∼100
images of human monocytes, stained for either TLR2 or TLR8, were acquired
at a magniﬁcation of 100× in an Olympus BX-41 epiﬂuorescence microscope
equipped with a digital camera (Q Imaging), using equal exposure time and
gain parameters. Regions of interest corresponding to individual cellular
contours were drawn using the Freehand selection tool of the ImageJ
software, and mean ﬂuorescence intensity and cellular area were calculated.
Statistical Methods. General statistical analysis was performed using GraphPad Prism 4.0. The fold increase or decrease for each speciﬁc gene transcript
assayed by quantitative RT-PCR and cytokine concentrations was compared
among the different stimuli using either a paired or unpaired Student’s t test
or the equivalent nonparametric method (i.e., Mann–Whitney U test). To
analyze changes over time, we used a nonparametric statistical test for trend
analysis (Kruskal–Wallis test), because a Gaussian distribution could not be
assumed. A P value <0.05 was considered signiﬁcant.
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from two different locations: most certainly from the plasma
membrane but also from an as yet undeﬁned cytosolic location/
structure, similar to the intracellular trafﬁcking of TLR8. Taken
as a whole, we envision a model in which a superior TLR2-receptor density would become available for signaling in phagosomal vacuoles than can occur at the plasma membrane. The
presence of speciﬁc “docking” molecules within the budding
phagosomal vacuole would thus provide an effective scaffold for
inserting spirochetal lipoproteins proximal to their cognate
receptors. A higher receptor density, in combination with a large
concentration of exposed and liberated lipoproteins, would thus
greatly improve TLR2 signaling efﬁciency.
Although cross-talk between TLR2 and TLR8 occurs following stimulation of PBMCs by their individual TLR ligands (61),
the transcriptional and translational responses shown here distinctively demonstrate that coordination between TLR2 and
TLR8 does occur in response to a live bacterium. How these
integrated responses facilitate control of the LD spirochete and
whether or not they are beneﬁcial or detrimental to individuals
with LD have only begun to be uncovered. Evidence from recently published studies suggests that endosomal TLR activation,
including TLR8, can have an impact on the ability of the host cell
to respond to stimulation of a different TLR (62, 63), including
TLR2 (62). Given that type I IFNs can shape a variety of
downstream inﬂammatory responses through positive and/or
negative regulation of the expression of hundreds of additional
genes involved in secondary host defenses, TLR8 activation is
likely to play a critical role in clearance of the spirochete and,
most importantly, disease control. Type I IFNs also can promote
inﬂammatory cell death of host cells (50, 64), a phenomenon that
we previously described in Bb-infected monocytes (4), and thus
may constitute an additional mechanism for controlling spirochetal replication. Whether or not the presence of tlr8 SNPs in
patients with LD affects spirochetal clearance and/or dissemination, and whether these SNPs are linked to disease progression
and/or the severity of the initial clinical presentation, needs to
be studied.
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